ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,150.40
-0.40%
Dow Jones
40,211.72
0.00%
Gold vs US Dollar
2,436.42
0.59%
Brent Oil
82.895
-1.71%
Bitcoin
63,932.41
-1.42%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Enzymotec Ltd. - Ordinary Shares (delisted) (ENZY)

  7. Enzymotec Ltd. - Ordinary Shares (delisted) (ENZY) News

ENZYMOTEC LTD. (ENZY)

Enzymotec Ltd. - Ordinary Shares (delisted)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ENZY
DateTimeSourceHeadlineSymbolCompany
02/02/201613:36Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
02/02/201613:30GlobeNewswire Inc.Enzymotec Announces Positive Outcome in ICC Arbitration AwardNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
28/01/201608:44GlobeNewswireNOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING IN ENZYMATICA AB (PUBL)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
28/01/201607:00GlobeNewswireEnzymatica signs acquisition agreement and prepares for international expansion with new share issueNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
04/01/201613:11Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
04/01/201613:00GlobeNewswire Inc.Enzymotec Updates Automatic Extension of Its Joint Venture Agreement With AAK Until December 31, 2019NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
21/12/201513:30GlobeNewswire Inc.Enzymotec Granted Mexican Patent for INFAT® Uses Related to Promoting Intestinal HealthNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
04/12/201522:13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
01/12/201513:30GlobeNewswire Inc.Enzymotec's InCog(TM), an Innovative Lipid Composition for Cognitive Functioning, Approved as Novel Food in EuropeNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
20/11/201514:03Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
12/11/201511:22Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
11/11/201512:30GlobeNewswire Inc.Enzymotec Ltd. Reports Third Quarter 2015 ResultsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
10/11/201513:30GlobeNewswire Inc.Enzymotec to Host a VAYA Pharma Analyst and Investor Day in New York City on November 19, 2015NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
09/11/201514:00GlobeNewswire Inc.Retrospective Analysis of the Effects of Enzymotec's Vayarin(R) Showed Significant Improvement of Emotional Status and Sleep ...NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
28/10/201520:05GlobeNewswire Inc.Enzymotec to Report Third Quarter 2015 Financial ResultsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
28/10/201512:30GlobeNewswire Inc.Enzymotec Ltd. Granted a New US Patent for Vayacog(R) in Pre-DementiaNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
12/08/201521:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
30/07/201511:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
25/06/201521:02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
15/06/201509:30GlobeNewswireEnzymatica rang in the company at Nasdaq First NorthNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
11/06/201521:31Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
08/06/201511:08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
20/05/201513:30GlobeNewswire Inc.Enzymotec Ltd. to Participate in the Jefferies 2015 Global Healthcare ConferenceNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
07/05/201521:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
07/05/201512:30GlobeNewswire Inc.Enzymotec Ltd. Reports First Quarter 2015 Unaudited Financial ResultsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
30/04/201513:30GlobeNewswire Inc.Enzymotec Ltd. Announces Positive Results Comparing Vayarol(R) to Ethyl Esters of Omega-3NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
23/04/201513:30GlobeNewswire Inc.Enzymotec to Report First Quarter 2015 Financial ResultsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
24/03/201513:23GlobeNewswire Inc.Enzymotec Ltd. Reports a Decision of the U.S. Patent and Trademark OfficeNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
18/03/201513:14Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
13/03/201513:47GlobeNewswire Inc.Enzymotec Ltd. Granted New Patents in the United States and Australia Relevant to Phospholipid-Based ProductsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
 Showing the most relevant articles for your search:NASDAQ:ENZY

Your Recent History

LSE
32OC
Ml Hennes&m.'b'
NASDAQ
CENT
Central Garden and Pet
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved